Undervalued Small-Cap Stocks on NAS February 2026

February 26, 2026

Small, Micro and Nano-Cap

Stocks in the Small, Micro and Nano Market Cap groups have a market capitalization of less than $2 billion.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks on the NAS

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
NMRA Neumora Therapeutics, Inc 2.09 9.76 7.67 (367.0%) 977381 337.4 0.0 0.0
IOVA Iovance Biotherapeutics I 2.20 9.40 7.20 (327.3%) 9312822 710.3 0.0 0.0
RXST Rxsight Inc 12.62 46.40 33.78 (267.7%) 881150 511.2 0.0 0.0
XRX Xerox Corp 2.48 8.52 6.04 (243.4%) 3416454 310.5 11.0 -0.2
AVXL Anavex Life Sciences Corp 3.80 11.04 7.24 (190.5%) 2720451 323.3 0.0 -9.8
HELE Helen of Troy Ltd 21.00 60.81 39.81 (189.6%) 739774 484.4 0.0 0.0
SPT Sprout Social Inc 11.04 31.69 20.65 (187.0%) 1140916 639.1 0.0 0.0
ACHC Acadia Healthcare Company 14.28 40.74 26.46 (185.3%) 3727067 1314.3 0.0 12.3
RCKT Rocket Pharmaceuticals In 3.39 9.66 6.27 (185.0%) 2365888 373.2 0.0 0.0
ULH Universal Logistics Holdi 17.33 47.66 30.33 (175.0%) 61081 456.6 2.4 0.0
All data provided as at market close December 13, 2025.

Company Details

Neumora Therapeutics, Inc

NMRA:NAS

Close Price

2.09

Our Valuation

9.76

% Difference

366.99

Market Cap ($M)

337

P/E Ratio

0.0

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder.

Access the stockcalc valuation


Iovance Biotherapeutics I

IOVA:NAS

Close Price

2.20

Our Valuation

9.40

% Difference

327.27

Market Cap ($M)

710

P/E Ratio

0.0

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Access the stockcalc valuation


Rxsight Inc

RXST:NAS

Close Price

12.62

Our Valuation

46.40

% Difference

267.67

Market Cap ($M)

511

P/E Ratio

0.0

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

Access the stockcalc valuation


Xerox Corp

XRX:NAS

Close Price

2.48

Our Valuation

8.52

% Difference

243.41

Market Cap ($M)

310

P/E Ratio

-0.2

Xerox Holdings Corporation, together with its subsidiaries, operates as a workplace technology company that integrates hardware, services, and software for enterprises in North America, Latin America, Europe, the Middle East, Africa, India, and internationally. It operates in two segments: Print and Other, and Xerox Financial Services (XFS).

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Anavex Life Sciences Corp

AVXL:NAS

Close Price

3.80

Our Valuation

11.04

% Difference

190.53

Market Cap ($M)

323

P/E Ratio

-9.8

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer .

Access the stockcalc valuation


Helen of Troy Ltd

HELE:NAS

Close Price

21.00

Our Valuation

60.81

% Difference

189.57

Market Cap ($M)

484

P/E Ratio

0.0

Helen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates in two segments: Home & Outdoor and Beauty & Wellness.

Access the stockcalc valuation


Sprout Social Inc

SPT:NAS

Close Price

11.04

Our Valuation

31.69

% Difference

187.05

Market Cap ($M)

639

P/E Ratio

0.0

Sprout Social, Inc. designs, develops, and operates a web-based social media management platform in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides cloud software for social messaging, data and workflows in a unified system of record, intelligence, and action.

Access the stockcalc valuation


Acadia Healthcare Company

ACHC:NAS

Close Price

14.28

Our Valuation

40.74

% Difference

185.27

Market Cap ($M)

1314

P/E Ratio

12.3

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Access the stockcalc valuation


Rocket Pharmaceuticals In

RCKT:NAS

Close Price

3.39

Our Valuation

9.66

% Difference

185.03

Market Cap ($M)

373

P/E Ratio

0.0

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Access the stockcalc valuation


Universal Logistics Holdi

ULH:NAS

Close Price

17.33

Our Valuation

47.66

% Difference

174.99

Market Cap ($M)

457

P/E Ratio

0.0

Universal Logistics Holdings, Inc. provides customized transportation and logistics solutions in the United States, Mexico, Canada, and Colombia. It operates through three segments: Contract Logistics, Intermodal, and Trucking.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Neumora Therapeutics, and Iovance Biotherapeutics I are the most undervalued Small-Cap stocks on the NAS. See which other companies made the Small-Cap list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-february-2026
Neumora Therapeutics, $NMRA and Iovance Biotherapeutics I $IOVA are the most undervalued Small-Cap stocks on the #NAS. See the full list of Small-Cap stocks here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-february-2026
Neumora Therapeutics, and Iovance Biotherapeutics I are the most undervalued Small-Cap stocks on the NAS. See which other companies made the Small-Cap list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-february-2026

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.